Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychology of Religion

Study finds religion influences how you experience psychedelic drugs

by Eric W. Dolan
August 25, 2018
in Psychology of Religion, Psychopharmacology
(Photo credit: Lorelyn Medina)

(Photo credit: Lorelyn Medina)

Share on TwitterShare on Facebook

New research provides evidence that a person’s religious beliefs can shape their experiences with psychedelic drugs like LSD and psilocybin mushrooms. The findings were published in the Journal of Psychoactive Drugs.

“I first developed interest in psychedelic drugs after watching some popular documentaries on the subject as an undergrad. After looking more into the academic work for a class project, I quickly became fascinated because much of what I came across in the literature was related to the mystical or religious characteristics of the psychedelic experience,” said study author Logan Neitzke-Spruill of Minnesota State University, Mankato.

“Being fairly skeptical of religion, I was intrigued that under the proper conditions psychedelics are able to produce mystical, religious, or otherwise deeply meaningful experiences which can be employed for therapeutic purposes.”

“Further, I became really interested in the concepts of set and setting, and this notion that, although biology is important, there is much more to the drug experience than what is happening at the physiological level.”

The study of 119 participants found that religious people and those who took psychedelic drugs with religious intent tended to report stronger mystical experiences.

Religious participants were more likely to say that they had a psychedelic experience in which they had no sense of time or space, experienced a feeling of awe, and realized the oneness of all things.

“Set and setting are incredibly important in shaping the psychedelic experience,” Neitzke-Spruill told PsyPost. “These concepts have become almost cliché at this point, at least within the psychedelic world, but I think our findings help reiterate their importance.”

“Specifically, our study shows that using psychedelics for spiritual or religious purposes positively influences scores on the mysticism scale, which illustrates how motivations for using psychedelics can impact the experience.”

“Responses to the survey also seem to indicate some level of awareness of the importance of set and setting among psychedelic users. For instance, more than 60% of respondents reported performing some type of ritual prior to using psychedelics,” Neitzke-Spruill said.

The study — like all research — includes some limitations. The participants were recruited from psychedelic-related websites and a large majority were white males.

“One major limitation is that our study relies on respondents’ recollection of events that may have occurred months or even years ago, which may impact their perceptions of the experience. Also, since we sampled from psychedelic related message boards, our results may not be representative of all those who use psychedelics,” Neitzke-Spruill explained.

“There are a number of questions that still need to be addressed regarding the influence of set and setting on the psychedelic experience. For example, how do specific beliefs impact the psychedelic experience and the potential for long term benefits?”

“Our study looked at religiosity, but it could have benefited from a more nuanced measure of religious beliefs. Furthermore, are certain motivations for using psychedelics more influential than others when it comes to shaping the experience and producing long term positive impacts? Are some physical settings more conducive to positive experiences and long term impacts for some people? Answering these questions may allow for more effective applications of these substances in therapeutic contexts.”

There has been a re-emergence of interest in psychedelic drugs in the scientific community. However, most research is still in the preliminary stages.

“There is a lot of excitement surrounding these substances again. It’s great that research is progressing, and it should be supported,” Neitzke-Spruill said. “But, science takes time and I don’t recommend that anyone take these substances recreationally. That being said, people do inevitably use these drugs, so promoting education aimed at reducing harms is very important.”

“Also, I’d like to thank my co-author and mentor, Carol Glasser, for being open to these ideas and helping me follow through on what began as a class project.”

The study, “A Gratuitous Grace: The Influence of Religious Set and Intent on the Psychedelic Experience“, was authored by Logan Neitzke-Spruill and Carol Glasser.

TweetSendScanShareSendPin11ShareShareShareShareShare

RELATED

ADHD drug shows promise in treating some symptoms of Alzheimer’s disease
Depression

Withdrawal symptoms are common after stopping antidepressants

May 23, 2025

Researchers analyzed data from 35 studies and found that over 40% of antidepressant users experienced withdrawal symptoms, including dizziness, irritability, and mood disturbances. The findings suggest the need for better tapering strategies and patient education.

Read moreDetails
Pills spilling out of a bottle on a table
ADHD

Common blood pressure drug shows promise for treating ADHD symptoms

May 22, 2025

Amlodipine, typically used for hypertension, may have brain-based effects that make it a candidate for ADHD treatment, according to new research.

Read moreDetails
Psychedelic’s anti-anxiety effects can be separated from hallucinations by targeting specific brain circuits
Neuroimaging

Psychedelic’s anti-anxiety effects can be separated from hallucinations by targeting specific brain circuits

May 19, 2025

A mouse study published in Science shows that stimulating a specific set of brain cells activated by a psychedelic drug can reduce anxiety without triggering hallucination-like behavior, pointing to new possibilities for targeted mental health treatments.

Read moreDetails
New study sheds light on which post-psychedelic difficulties last longest and what helps people cope
Psychedelic Drugs

New study sheds light on which post-psychedelic difficulties last longest and what helps people cope

May 18, 2025

While many praise psychedelics for their therapeutic power, new research reveals that some users face long-lasting psychological challenges. This study explores the most common difficulties and the coping strategies people turn to for support and recovery.

Read moreDetails
Young adults who drink heavily report more romantic highs and lows
Addiction

Young adults who drink heavily report more romantic highs and lows

May 18, 2025

A new study of heavy-drinking young adults found that drinking more on a given day was linked to both regretted and positive romantic or sexual experiences. For women, using cannabis alongside alcohol appeared to reduce the likelihood of regret.

Read moreDetails
Amphetamine scrambles the brain’s sense of time by degrading prefrontal neuron coordination
Neuroimaging

Amphetamine scrambles the brain’s sense of time by degrading prefrontal neuron coordination

May 18, 2025

Researchers have found that amphetamine alters how the brain processes time, increasing variability in the activity of neurons that encode temporal information. The study provides insight into how the drug affects executive function and decision-making at the neural level.

Read moreDetails
Inhaled DMT produces rapid and lasting antidepressant effects in treatment-resistant depression
Ayahuasca

Inhaled DMT produces rapid and lasting antidepressant effects in treatment-resistant depression

May 17, 2025

Vaporized DMT produced fast and lasting improvements in depression symptoms and suicidal ideation, according to a new phase 2a trial, highlighting its potential as a scalable, non-invasive alternative to conventional and long-acting psychedelic treatments for severe depression.

Read moreDetails
Single dose of 5-MeO-DMT alters gene expression in brain and reduces anxiety-like behavior in stressed mice
Psychedelic Drugs

Single dose of 5-MeO-DMT alters gene expression in brain and reduces anxiety-like behavior in stressed mice

May 16, 2025

New findings reveal that 5-MeO-DMT, a fast-acting psychedelic, can change brain gene activity and reduce anxiety-related behavior in stressed mice, offering promising insights into its lasting effects and potential use in treating anxiety disorders.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Neuroscientists challenge “dopamine detox” trend with evidence from avoidance learning

Non-right-handedness is more common across multiple mental health conditions

Withdrawal symptoms are common after stopping antidepressants

Anxious attachment linked to depression spillover in romantic relationships, study finds

Scientists find 16 new Alzheimer’s-linked genes using multi-ancestry genome data

Groundbreaking AI model uncovers hidden patterns of political bias in online news

Gut bacteria can influence how brain proteins are modified by carbohydrates

“Tiger mom” parenting boosts teens’ cognitive skills but undermines emotional development, study suggests

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy